Table 4.
Preferences of respondents for allocating resources when treatment costs are equal between rare and common disease, by survey scenario
| Scenario | No randomised to scenario | % (95% CI) | ||
|---|---|---|---|---|
| Prioritise rare disease | Prioritise common disease | Indifferent | ||
| All extra funds scenarios | 1289 | 10.2 (8.6 to 11.9) | 19.9 (17.8 to 22.1) | 69.8 (67.3 to 72.3) |
| Extra funds (no information) | 258 | 15.9 (11.4 to 20.4) | 25.2 (19.9 to 30.5) | 58.9 (52.9 to 64.9) |
| Extra funds (disease severity and treatment benefit scenarios) | 1031 | 8.8 (7.1 to 10.6) | 18.6 (16.2 to 21.0) | 72.5 (69.8 to 75.3) |
| Severe disease, high benefit | 256 | 7.8 (4.5 to 11.1) | 15.2 (10.8 to 19.6) | 77.0 (71.8 to 82.1) |
| Severe disease, low benefit | 257 | 9.7 (5.1 to 13.4) | 21.0 (16.0 to 26.0) | 69.3 (63.6 to 74.9) |
| Moderate disease, high benefit | 258 | 9.3 (5.7 to 12.9) | 16.7 (12.1 to 21.2) | 74.0 (68.7 to 79.4) |
| Moderate disease, low benefit | 260 | 8.5 (5.1 to 11.9) | 21.5 (16.4 to 26.5) | 70.0 (64.4 to 76.6) |
| Fixed funds (severe disease, high benefit) | 258 | 15.9 (11.4 to 20.4) | 43.4 (37.3 to 49.5) | 40.7 (34.7 to 46.7) |
| All scenarios | 1547 | 11.2 (9.6 to 12.8) | 23.8 (21.7 to 26.0) | 65.0 (62.6 to 67.3) |